Key terms
About KIDS
OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest KIDS news
Mar 15
4:38pm ET
OrthoPediatrics files $250M mixed securities shelf
Mar 11
10:10pm ET
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), OrthoPediatrics (KIDS) and RegenXBio (RGNX)
Mar 11
7:22am ET
OrthoPediatrics Corp Enhances Investor Relations Efforts
Mar 11
6:30am ET
Analysts Conflicted on These Healthcare Names: MDxHealth (MDXH), OrthoPediatrics (KIDS) and Karuna Therapeutics (KRTX)
Mar 10
1:01am ET
Bad News for Orthopediatrics Corp Stock: This New Risk Has Been Added
Mar 08
7:20am ET
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Compugen (CGEN) and OrthoPediatrics (KIDS)
Mar 07
2:51pm ET
OrthoPediatrics price target raised to $34 from $32 at Stifel
Mar 07
12:15pm ET
OrthoPediatrics Earns Buy Rating from Analyst on Strong Q4 Performance and Promising Growth Outlook
Mar 07
12:30am ET
Analysts Offer Insights on Healthcare Companies: Elevation Oncology (ELEV) and OrthoPediatrics (KIDS)
Mar 06
4:26pm ET
OrthoPediatrics management to meet virtually with Piper Sandler
Mar 06
4:19pm ET
OrthoPediatrics sees FY24 revenue $197M-$200M, consensus $182.9M
Mar 06
4:17pm ET
OrthoPediatrics reports Q4 adjusted EPS (23c), consensus (28c)
Feb 29
6:45am ET
Buy Rating for OrthoPediatrics: A Comprehensive Analysis of Market Position and Financial Growth Potential
Feb 28
12:50pm ET
OrthoPediatrics participates in a conference call with BTIG
Feb 28
4:55am ET
OrthoPediatrics participates in a conference call with BTIG
Feb 22
4:21pm ET
OrthoPediatrics participates in a conference call with BTIG
Jan 25
6:07am ET
OrthoPediatrics downgraded to Hold from Buy at Truist
Jan 09
7:40am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Danaher (DHR), Blueprint Medicines (BPMC) and OrthoPediatrics (KIDS)
Jan 08
12:15pm ET
Buy Rating Endorsed for OrthoPededics Amid Positive Financial Outlook and Strategic Acquisition
Jan 08
8:16am ET
OrthoPediatrics sees FY24 revenue $197M-$200M, consensus $177.7M
Jan 08
8:16am ET
OrthoPediatrics reports preliminary FY23 revenue $148.7M, consensus $148.88M
Jan 08
8:15am ET
OrthoPediatrics reports preliminary Q4 revenue $37.6M, consensus $37.77M
Jan 08
8:15am ET
OrthoPediatrics announces acquisition of Boston Orthotics & Prosthetics
Jan 07
5:33am ET
BTIG Sticks to Its Buy Rating for OrthoPediatrics (KIDS)
Jan 02
9:18am ET
OrthoPediatrics (KIDS) Receives a Buy from BTIG
Dec 31
5:18am ET
BTIG Remains a Buy on OrthoPediatrics (KIDS)
Dec 22
7:53am ET
OrthoPediatrics price target raised to $39 from $35 at Truist
No recent news articles are available for KIDS
No recent press releases are available for KIDS
KIDS Financials
Key terms
Ad Feedback
KIDS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KIDS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
